Process for the production of 2'-branched nucleosides
First Claim
Patent Images
1. A process for preparing a 3′
- -O-amino acid ester nucleoside, comprising;
(a) coupling an optionally protected, optionally substituted, ribofuranose with an unprotected nucleoside base and a silylating reagent in the presence of a Lewis acid to form an optionally protected nucleoside;
(b) optionally reacting the protected nucleoside from step (a) with a deprotecting reagent to provide an unprotected nucleoside if necessary;
(c) optionally reacting the amine group of the protected or unprotected nucleoside if the nucleoside has an amine group, with an amine-protecting reagent;
(d) optionally reacting the protected or unprotected nucleoside with a silylating reagent to provide a 5′
-O-silyl-protected nucleoside;
(e) reacting the protected or unprotected nucleoside with a protected amino acid derivative optionally with one or more coupling reagents to form a protected 3′
-O-amino acid ester;
(f) optionally refluxing the product from step (e) with a reagent that removes the silyl protecting group from the 5′
-C and the formamidine-protecting group from the nucleosidic amine if needed; and
(g) optionally reacting the product from step (f) with a reagent that removes the protecting group from the 3′
-O-amino acid ester, thereby producing a substituted or unsubstituted 3′
-O-ester-substituted nucleoside.
5 Assignments
0 Petitions
Accused Products
Abstract
The present invention provides an improved process for preparing β-D and β-L 2′-C-methyl-nucleosides and 2′-C-methyl-3′-O-ester nucleosides.
175 Citations
88 Claims
-
1. A process for preparing a 3′
- -O-amino acid ester nucleoside, comprising;
(a) coupling an optionally protected, optionally substituted, ribofuranose with an unprotected nucleoside base and a silylating reagent in the presence of a Lewis acid to form an optionally protected nucleoside;
(b) optionally reacting the protected nucleoside from step (a) with a deprotecting reagent to provide an unprotected nucleoside if necessary;
(c) optionally reacting the amine group of the protected or unprotected nucleoside if the nucleoside has an amine group, with an amine-protecting reagent;
(d) optionally reacting the protected or unprotected nucleoside with a silylating reagent to provide a 5′
-O-silyl-protected nucleoside;
(e) reacting the protected or unprotected nucleoside with a protected amino acid derivative optionally with one or more coupling reagents to form a protected 3′
-O-amino acid ester;
(f) optionally refluxing the product from step (e) with a reagent that removes the silyl protecting group from the 5′
-C and the formamidine-protecting group from the nucleosidic amine if needed; and
(g) optionally reacting the product from step (f) with a reagent that removes the protecting group from the 3′
-O-amino acid ester, thereby producing a substituted or unsubstituted 3′
-O-ester-substituted nucleoside. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 46, 47)
- -O-amino acid ester nucleoside, comprising;
-
19. A process for preparing a nucleoside comprising the steps of:
-
(a) coupling 1,2,3,5-tetra-O-benzoyl-2-C-methyl-β
-D-ribofuranose with cytosine in the presence of BSA and 5 nCl4, to form 4-amino-1-(3,4-dibenzoyloxymethyl-5-benzyloxymethyl-3-methyl-tetrahydrofuran-2-yl)-1H-pyrimidin-2-one;
(b) reacting the 4-amino-1-(3,4-dibenzoyloxymethyl-5-benzyloxymethyl-3-methyl-tetrahydrofuran-2-yl)-1H-pyrimidin-2-one from step (a) with sodium methoxide to remove the benzoyl protecting groups, thereby providing 4-amino-1-(3,4-dihydroxy-5-hydroxymethyl-3-methyl-tetrahydro-furan-2-yl)-1H-pyrimidin-2-one;
(c) reacting the 4-amino-1-(3,4-dihydroxy-5-hydroxymethyl-3-methyl-tetra-hydrofuran-2-yl)-1H-pyrimidin-2-one from step (b) with N,N-dimethyl-formamide dimethyl acetal to protect the N4-amino group, thereby producing N-[1-(3,4-dihydroxy-5-hydroxymethyl-3-methyl-tetrahydrofuran-2-yl)-2-oxo-1,2-dihydro-pyrimidin-4-yl]-N,N-dimethyl formamidine;
(d) reacting the nucleoside from either of steps b) or c) with the silylating reagent TBDPSCl to provide N′
-{1-[5-(tert-butyl-diphenyl-silanyloxymethyl)-3,4-dihydroxy-3-methyl-tetrahydrofuran-2-yl]-2-oxo-1,2-dihydro-pyrimidin-4-yl}-N,N-dimethyl-formamidine;
(e) reacting the N′
-{1-[5-(tert-butyl-diphenyl-silanyloxymethyl)-3,4-dihydroxy-3-methyl-tetrahydrofuran-2-yl]-2-oxo-1,2-dihydro-pyrimidin-4-yl}-N,N-dimethyl-formamidine with N-BOC-L-valine and EDC in dichloromethane to provide 2-tert-butoxycarbonylamino-3-methyl-butyric acid 2-(tert-butyl-diphenyl-silanyloxymethyl)-5-[4-(dimethylamino-methyleneamino)-2-oxo-2H-pyrimidin-1-yl]-4-hydroxy-4-methyl-tetrahydrofuran-3-yl ester;
(f) removing the silyl-protecting group and the formamidine group from 2-tert-butoxycarbonylamino-3-methyl-butyric acid 2-(tert-butyl-diphenyl-silanyl-oxymethyl)-5-[4-(dimethylamino-methyleneamino)-2-oxo-2H-pyrimidin-1-yl]-4-hydroxy-4-methyl-tetrahydrofuran-3-yl ester in step (e) by refluxing the compound with NH4F to form 2-tert-butoxy-carbonylamino-3-methyl-butyric acid 5-(4-amino-2-oxo-2H-pyrimidin-1-yl)-4-hydroxy-2-hydroxymethyl-4-methyl-tetrahydrofuran-3-yl ester; and
(g) removing the BOC-protecting group from the 3′
-O-valinyl-ester substituent by reacting the 2-tert-Butoxycarbonylamino-3-methyl-butyric acid 5-(4-amino-2-oxo-2H-pyrimidin-1-yl)-4-hydroxy-2-hydroxymethyl-4-methyl-tetrahydro-furan-3-yl ester from step (f) with HCl to provide 2-amino-3-methyl-butyric acid 5-(4-amino-2-oxo-2H-pyrimidine-1-yl)-4-hydroxy-2-hydroxymethyl-4-methyl-tetrahydro-furan-3-yl ester (dihydro-chloride salt).
-
-
20. A process for preparing a furanose comprising:
-
(a) reacting aqueous CaO with a cyclic ether that contains a hydroxyl and a CH2OH on the carbon adjacent to the ring oxygen, thereby forming a furanyl lactone;
(b) optionally protecting the furanyl lactone with a protecting group if necessary;
(c) reacting the optionally protected furanyl lactone with a reducing agent to reduce the lactone to a hydroxyl group, creating a furanose product compound; and
(d) optionally reacting the furanose product compound with a protecting group. - View Dependent Claims (21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35)
-
-
36. A process comprising:
-
(a) reacting aqueous CaO with D-fructose for about 5 hours to about 25 hours at a temperature from about 23°
C. to about 40°
C.;
(b) reacting the product from step (a) with CO2 and oxalic acid for about 8 hours to about 12 hours, to form 2-C-methyl-D-ribonolactone;
(c) reacting 2-C-methyl-D-ribonolactone with benzoyl chloride for about 3 hours to about 6 hours to provide 2,3,5-tri-O-benzoyl-2-C-methyl-D-ribonolactone;
(d) reducing 2,3,5-tri-O-benzoyl-2-C-methyl-D-ribonolactone with Red-Al/ethanol for about 30 to about 60 minutes at a temperature of from about −
5°
C. to about 0°
C. to afford 2,3,5-tri-O-benzoyl-2-C-methyl-β
-D-ribofuranose;
(e) benzoylating 2,3,5-tri-O-benzoyl-2-C-methyl-o-D-ribofuranose in solvent for about 4 hours to about 14 hours at a temperature of from about 0°
C. to about 50°
C. to form 1,2,3,5-tetra-O-benzoyl-2-C-methyl-β
-D-ribofuranose; and
(f) optionally isolating the 1,2,3,5-tetra-O-benzoyl-2-C-methyl-β
-D-ribo-furanose. - View Dependent Claims (37, 38, 39, 40, 41, 42, 43, 44, 45)
-
-
48. A process for preparing a furanyl lactone comprising:
(a) reacting aqueous CaO with a cyclic ether that contains a hydroxyl and a CH2OH on the carbon adjacent to the ring oxygen, thereby forming a furanyl lactone.
-
49. A process for preparing a 2-C-methyl-D-ribonolactone, the process comprising:
-
(a) reacting aqueous CaO with D-fructose for about 5 hours to about 25 hours at a temperature from about 23°
C. to about 40°
C.;
(b) reacting the product from step (a) with CO2 and oxalic acid for about 8 hours to about 12 hours, to form 2-C-methyl-D-ribonolactone.
-
-
50. A process for preparing an optionally protected 2-C-methyl-β
- -D-ribofuranose compound comprising;
(a) reducing an optionally protected 2-C-methyl-D-ribonolactone with Red-Al/ethanol to obtain an optionally protected 2-C-methyl-β
-D-ribofuranose.
- -D-ribofuranose compound comprising;
-
51. A process for preparing an optionally protected nucleoside, comprising:
(a) coupling an optionally protected, optionally substituted, ribofuranose with an unprotected nucleoside base and a silylating reagent in the presence of a Lewis acid to form an optionally protected nucleoside.
-
52. A process for preparing an optionally protected β
- -D-2′
-C-methyl-cytidine comprising the steps of;
(a) coupling an optionally protected 2-C-methyl-β
-D-ribofuranose with cytosine in the presence of BSA and SnCl4, to form an optionally protected β
-D-2′
-C-methyl-cytidine.
- -D-2′
-
53. A process for preparing a 2′
- -C-methyl-cytidine comprising the steps of;
(a) reacting cytosine and an activator, optionally in the presence of a Lewis acid, with an optionally protected 2-C-methyl-β
-D-ribofuranose to form an optionally protected 2′
-C-methyl-cytidine
wherein each P1, P2, P3, and P4 is independently hydrogen or a suitable oxygen protecting group;
and then(b) optionally deprotecting the optionally protected 2′
-C-methyl-cytidine of the previous step to form 2′
-C-methyl-cytidine (VI)
if necessary. - View Dependent Claims (54, 55, 56, 57, 58, 59, 60, 61, 62, 63)
- -C-methyl-cytidine comprising the steps of;
-
64. A process for preparing an optionally protected 2-C-methyl-β
- -D-ribofuranose comprising the steps of;
(a) reducing an optionally protected 2-C-methyl-D-ribonic lactone with a reducing agent
wherein each P1, P2, and P3 is independently hydrogen or a suitable oxygen protecting group;
and then(b) optionally protecting the ribofuranose derivative compound of the previous step to form an optionally protected 2-C-methyl-β
-D-ribofuranose
wherein P4 is independently hydrogen or a suitable oxygen protecting group. - View Dependent Claims (65, 66, 67, 68)
- -D-ribofuranose comprising the steps of;
-
69. A process for preparing an optionally protected 2-C-methyl-D-ribonic lactone comprising the steps of:
-
(a) reacting D-fructose with CaO;
and then,(b) optionally protecting the lactone, to form an optionally protected 2-C-methyl-D-ribonic lactone
wherein each P1, P2, and P3 is independently hydrogen or a suitable oxygen protecting group. - View Dependent Claims (70, 71, 72, 73, 74, 75)
-
-
76. A process for preparing an optionally protected 2′
- -C-methyl-D-cytidine from D-fructose, comprising the steps of;
(a) reacting D-fructose with CaO to obtain a 2-C-methyl-D-ribonic-γ
-lactone;
(b) optionally protecting the lactone to form an optionally protected 2-C-methyl-D-ribonic lactone, if necessary;
wherein each P1, P2, and P3 is independently hydrogen or a suitable oxygen protecting group;
(c) reacting the optionally protected 2-C-methyl-D-ribonic lactone with a reducing agent;
wherein each P1, P2, and P3 is independently hydrogen or a suitable oxygen protecting group;
(d) optionally protecting the ribofuranose derivative compound of the previous step to form an optionally protected 2-C-methyl-β
-D-ribofuranose if necessary,
wherein P4 is independently hydrogen or a suitable oxygen protecting group;
(e) reacting the optionally protected 2-C-methyl-β
-D-ribofuranose with cytosine and an activator, optionally in the presence of a Lewis acid, to form an optionally protected 2′
-C-methylcytidine
wherein each P1, P2, P3, and P4 is independently hydrogen or a suitable oxygen protecting group;
and then(f) optionally deprotecting the optionally protected 2′
-C-methylcytidine to form optionally protected 2′
-C-methylcytidine
if necessary. - View Dependent Claims (77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88)
- -C-methyl-D-cytidine from D-fructose, comprising the steps of;
Specification